Comparing planning time, delivery time and plan quality for IMRT, RapidArc and Tomotherapy.

Journal of Applied Clinical Medical Physics
Mike OliverWayne A Beckham

Abstract

The purpose of this study is to examine plan quality, treatment planning time, and estimated treatment delivery time for 5- and 9-field sliding window IMRT, single and dual arc RapidArc, and tomotherapy. For four phantoms, 5- and 9-field IMRT, single and dual arc RapidArc and tomotherapy plans were created. Plans were evaluated based on the ability to meet dose-volume constraints, dose homogeneity index, radiation conformity index, planning time, estimated delivery time, integral dose, and volume receiving more than 2 and 5 Gy. For all of the phantoms, tomotherapy was able to meet the most optimization criteria during planning (50% for P1, 67% for P2, 0% for P3, and 50% for P4). RapidArc met less of the optimization criteria (25% for P1, 17% for P2, 0% for P3, and 0% for P4), while IMRT was never able to meet any of the constraints. In addition, tomotherapy plans were able to produce the most homogeneous dose. Tomotherapy plans had longer planning time, longer estimated treatment times, lower conformity index, and higher integral dose. Tomotherapy plans can produce plans of higher quality and have the capability to conform dose distributions better than IMRT or RapidArc in the axial plane, but exhibit increased dose superior an...Continue Reading

References

Apr 10, 1999·Seminars in Radiation Oncology·T R Mackie
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·UNKNOWN Intensity Modulated Radiation Therapy Collaborative Working Group
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Cedric X YuCarl M Mansfield
May 30, 2003·Medical Physics·Joseph O DeasyVanessa H Clark
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Wim DuthoyWilfried De Neve
Jan 10, 2004·Medical Physics·John BalogJeff Kapatoes
Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Eugene WongGlenn S Bauman
Jun 30, 2005·Medical Physics·M W KissickE T Soisson
Dec 24, 2005·Medical Physics·Guowei ZhangCedric Yu
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Eric J Hall
Jul 25, 2006·Physics in Medicine and Biology·Tarek HalabiThomas Bortfeld
Aug 4, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·George RodriguesTomas Kron
Oct 3, 2006·Seminars in Radiation Oncology·John D FenwickT Rock Mackie
Dec 7, 2006·Physics in Medicine and Biology·Aswin L HoffmannHenk Huizenga
Dec 30, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mike OliverFrancisco Perera
Mar 31, 2007·International Journal of Radiation Oncology, Biology, Physics·David CraftThomas Bortfeld
Jun 9, 2007·Medical Physics·Adam GladwishEugene Wong
Jul 21, 2007·Frontiers of Radiation Therapy and Oncology·Joseph O DeasyKonstantin Zakaryan
Aug 21, 2007·International Journal of Radiation Oncology, Biology, Physics·Daliang CaoDavid M Shepard
Oct 9, 2007·Physics in Medicine and Biology·Sebastiaan BreedveldBen J M Heijmen
Jan 22, 2008·International Journal of Radiation Oncology, Biology, Physics·Jeremy D RubenAlistair Hunter
Apr 9, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mauro IoriAlan E Nahum
Aug 5, 2008·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Chengyu ShiNiko Papanikolaou
Aug 12, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luca CozziAntonella Fogliata
Sep 2, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Antonella FogliataLuca Cozzi
Oct 22, 2008·Physics in Medicine and Biology·Chao WangCedric X Yu
Dec 17, 2008·Physics in Medicine and Biology·Thomas Bortfeld, Steve Webb
Jan 30, 2009·Medical Physics·Cedric X YuMichelle Svatos

❮ Previous
Next ❯

Citations

Oct 27, 2010·Radiation Oncology·Barbara DoblerOliver Koelbl
Oct 9, 2012·Medical Physics·Gregory T BetzelCedric X Yu
Feb 11, 2012·Medical Physics·David CraftThomas Bortfeld
Feb 11, 2014·Medical Physics·David CraftJan Unkelbach
Jun 17, 2014·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Elizabeth FordeThomas Eade
Sep 2, 2014·Acta Oncologica·Kristoffer PeterssonCrister Ceberg
May 4, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·P FenogliettoD Azria
Jul 2, 2015·Medical Physics·Zhen TianSteve B Jiang
May 17, 2011·International Journal of Radiation Oncology, Biology, Physics·Chris BeltranThomas E Merchant
May 17, 2015·Medical Physics·Esther WildUwe Oelfke
Oct 4, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Spencer MartinSlav Yartsev
May 1, 2016·International Journal of Radiation Oncology, Biology, Physics·Lionel PerrierPhilippe Giraud
Jun 24, 2015·Journal of Applied Clinical Medical Physics·Sonja KatayamaFlorian Sterzing
Nov 15, 2012·Journal of Applied Clinical Medical Physics·Kai YangNeelam Tyagi
Sep 17, 2013·Journal of Applied Clinical Medical Physics·Ulrich W LangnerJonathan M Feddock
Nov 22, 2013·Journal of Applied Clinical Medical Physics·Monica W K KanPeter K N Yu
Jun 4, 2014·Journal of Applied Clinical Medical Physics·Leonie RudofskyFlorian Sterzing
Jun 1, 2013·The Oncologist·Dirk Van GestelVincent Gregoire
Feb 19, 2011·Journal of Applied Clinical Medical Physics·David JollyJuergen Meyer
Aug 17, 2011·Journal of Applied Clinical Medical Physics·Michael OliverWayne A Beckham
Jun 1, 2014·Journal of Medical Radiation Sciences·Craig A ElithHelen M Warren-Forward
Sep 17, 2017·Radiation Oncology·Shih-Ming HsuChia-Ying Tseng

❮ Previous
Next ❯

Software Mentioned

IMAT
Analytical Anisotropic Algorithm ( AAA
Elekta
RapidArc
TomoTherapy
TOMO
Eclipse
Computational Environment for Radiotherapy Research ( CERR
VMAT
Varian

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.